IMPORTANT NOTICE to Health Care Workers Using the Protocol for High-Dose Intravenous Ascorbic Acid (Vitamin C) for the Treatment of Cancer in Patients Who Are Also Diabetic! It has been discovered that high-dose intravenous vitamin C (15 grams and higher) will cause a "False Positive" on finger stick blood glucose strips read on a "glucometer" within four hours after receiving the vitamin C infusion. If blood is taken from a vein and run on serum in a laboratory, there is no interference. For some reason, the strips are reading high levels of ascorbate as glucose. Please alert any diabetic patients of this potential complication. Again, it is a "False Positive" on the strips — the blood glucose does NOT change.

INTRAVENOUS VITAMIN C and CANCER

There is actually a wide spectrum of medical uses for vitamin C. Evidence exists documenting it as one of the best antiviral agents now available. Vitamin C can neutralize and eliminate a wide range of toxins. Vitamin C will enhance host resistance, greatly augmenting the immune system's ability to neutralize bacterial and fungal infections. The National Institutes of Health has published evidence demonstrating vitamin C's anti-cancer properties. With so many medical benefits, why do so few doctors know of them?" More about IVC and Cancer ►

For more research information, visit the Bio-Communications Research Institute official website: http://www.biocommunicationsresearch.org or http://www.bcrionline.org/ Research Information: Cancer Research Vitamin C Research Nutrient Studies

Vitamin C Research Articles:

A complete listing of research articles can be found at: http://www.bcrionline.org/articles.shtml

Intravenous Ascorbate as a Chemotherapeutic and Biologic Response Modifying Agent Bio-Communications Research Institute (1997) Pharmacokinetics of Vitamin C: Insights into the Oral and Intravenous Administration of Ascorbate Duconge J, Miranda-Massari J, González M, Jackson J, Warnock W, Riordan N Puero Rico Health Sciences Journal, 2008, 27(1):7-19 [Library Archive] Schedule-Dependence in Cancer Therapy: What is the True Scenario for Vitamin C? Duconge J, Miranda-Massari J, González M, Riordan N Orthomolecular Medicine, 2007, 22(1):21-26 [Library Archive] The Effect of High Dose IV Vitamin C on Plasma Antioxidant Capacity and Level of Oxidative Stress in Cancer Patients and Healthy Subjects Mikirova N, Jackson J, Riordan N Orthomolecular Medicine, 2007, 22(3):153-160 [Library Archive] Intravenously Administered Vitamin C as Cancer Therapy Three Cases Padayatty S, Riordan H, Hewitt S, Katz A, Hoffer L, Levine M Canadian Medical Association Journal, 2006, 174(7):937-942 [Library Archive] Vitamin C as an Ergogenic Aid González M, Miranda J, Riordan H Orthomolecular Medicine, 2006, 20(2):100-102 [Library Archive] False Positive Finger Stick Blood Glucose Readings After High-Dose Intravenous Vitamin C Jackson J, Hunninghake R, Krier C, Kirby R, Hyland G Orthomolecular Medicine, 2006, 21(4):188-190 [Library Archive] Orthomolecular Oncology Review: Ascorbic Acid and Cancer 25 Years Late Gonzalez M, Miranda-Massari J, Mora E, Guzman A, Riordan N, Riordan H, Casciari J, Jackson J, Roman-Franco A Integrative Cancer Therapies, 2005, 4(1):32-44 [Library Archive] Screening for Vitamin C in the Urine: Is it Clinically Significant? Jackson J, Wong K, Krier C, Riordan H Orthomolecular Medicine, 2005, 20(4):259-261 [Library Archive] A Pilot Clinical Study of Continuous Intravenous Ascorbate in Terminal Cancer Patients Riordan H, Casciari J, Gonzalez M, Riordan N, Miranda-Massari J, Jackson J Puero Rico Health Sciences Journal, 2005, 24(4):269-276 [Library Archive] Vitamin C Pharmacokinetics: Implications for Oral and Intravenous Use Padayatty S, Sun H, Wang Y, Riordan H, Hewitt S, Katz A, Wesley R, Levine M Annals of Internal Medicine, 2004, 140:533-7 [Library Archive] Intravenous Vitamin C as a Chemotherapy Agent: A Report on Clinical Cases Riordan H, Riordan N, Jackson J, Casciari J, Hunninghake R, Gonzalez M, Mora E, Miranda-Massari J, Rosario N, Rivera A Puero Rico Health Sciences Journal, 2004, 23(2):115-118 [Library Archive] Intravenous Ascorbic Acid as a Treatment for Severe Jellyfish Stings Kumar S, Miranda-Massari J, Gonzalez M, Riordan H Puero Rico Health Sciences Journal, 2004, 23(4):125-126 [Library Archive] Intravenous Ascorbic Acid: Protocol for its Application and Use Riordan H, Hunninghake R, Riordan N, Jackson J, Meng X, Taylor P, Casciari J, Gonzalez M, Miranda-Massari J, Mora E, Rosario N, Rivera A Puero Rico Health Sciences Journal, 2003, 22(3):287-290 [Library Archive] Sixteen-Year History with High Dose Intravenous Vitamin C Treatment for Various Types of Cancer and Other Diseases Jackson J, Riordan H, Bramhall N, Neathery S Orthomolecular Medicine, 2002, 17(2):117-119 [Library Archive] Vitamin C and Oxidative DNA Damage Revisited Gonzalez M, Riordan H, Miranda-Massari J Orthomolecular Medicine, 2002, 17(4):225-228 [Library Archive] Orthomolecular Oncology: A Mechanistic View of Antravenous Ascorbate's Chemotherapeutic Activity Gonzalez M, Miranda-Massari J, Mora E, Jimenez I, Matos M, Riordan H, Casciari J, Riordan N, Rodriguez M, Guzman A Puero Rico Health Sciences Journal, 2002, 21(1):39-41 [Library Archive] Cytotoxicity of Ascorbate, Lipoic Acid, and Other Antioxidants in Hollow Fibre in Vitro Tumours Casciari J, Riordan N, Schmidt T, Meng X, Jackson J, Riordan H British Journal of Cancer, 2001, 84(11):1544-1550 [Library Archive] The Effect of Alternating Magnetic Field Exposure and Vitamin C on Cancer Cells Mikirova N, Jackson J, Casciari, Riordan H Orthomolecular Medicine, 2001, 16(3):177-182 [Library Archive] Clinical and Experimental Experiences with Intravenous Vitamin C Riordan N, Casciari J, Riordan H Orthomolecular Medicine, 2000, 15(4):201-213 [Library Archive] Different Fatty Acid Composition Between Normal and Malignant Cell Lines Meng X, Riordan N, Riordan H, Jackson J, Zhong J, Li Y, Gonzalez M, McClune B, Pappan K BioMedicina, 1999, 2(4):s5-s7 May [Library Archive] Rethinking Vitamin C and Cancer: An Update on Nutritional Oncology González M, Mora E, Riordan N, Riordan H, Mójica P Cancer Prevention International, 1998, 3:215-224 [Library Archive] High-Dose Intravenous Vitamin C in the Treatment of a Patient with Renal Cell Carcinoma of the Kidney Riordan H, Jackson J, Riordan N, Schultz M Orthomolecular Medicine, 1998, 13(2):72-73 [Library Archive] Intravenous Vitamin C in a Terminal Cancer Patient Riordan N, Jackson J, Riordan H Orthomolecular Medicine, 1996, 11(2):80-82 [Library Archive] Intravenous Ascorbate as a Tumor Cytotoxic Chemotherapeutic Agent Riordan N, Riordan H, Meng X, Li Y, Jackson J Medical Hypotheses, 1995, 44(3):207-213 [Library Archive] High Dose Intravenous Vitamin C and Long Time Survival of a Patient with Cancer of Head of the Pancreas Jackson J, Riordan H, Hunninghake R, Riordan N Orthomolecular Medicine, 1995, 10(2):87-88 [Library Archive] Case Study: High Dose Intravenous Vitamin C in the Treatment of a Patient with Adrenocarcinoma of the Kidney Riordan H, Jackson J, Schultz Orthomolecular Medicine, 1990, 5(1):5-7 [Library Archive]